Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up von Lahaye, Tanja, Riehm, Birte, Berger, Ute, Paschka, Peter, Müller, Martin C, Kreil, Sebastian, Merx, Kirsten, Schwindel, Uwe, Schoch, Claudia, Hehlmann, Rüdiger, Hochhaus, Andreas

Volltext

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 von REITER, Andreas, WALZ, Christoph, VANSTRAELEN, Danny, BARKER, Helen F, TAYLOR, Peter C, O'DRISCOLL, Aisling, BENEDETTI, Fabio, RUDOLPH, Cornelia, KOLB, Hans-Jochem, HOCHHAUS, Andreas, HEHLMANN, Rudiger, CHASE, Andrew, WATMORE, Ann, CROSS, Nicholas C. P, SCHOCH, Claudia, BLAU, Ilona, SCHLEGELBERGER, Brigitte, BERGER, Ute, TELFORD, Nick, ARULIAH, Shilani, YIN, John A

Volltext

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia von Hehlmann, Rüdiger, Berger, Ute, Pfirrmann, Markus, Heimpel, Hermann, Hochhaus, Andreas, Hasford, Joerg, Kolb, Hans-Jochem, Lahaye, Tanja, Maywald, Ole, Reiter, Andreas, Hossfeld, Dieter K., Huber, Christoph, Löffler, Helmut, Pralle, Hans, Queisser, Wolfgang, Tobler, Andreas, Nerl, Christoph, Solenthaler, Max, Goebeler, Mariele E., Griesshammer, Martin, Fischer, Thomas, Kremers, Stephan, Eimermacher, Hartmut, Pfreundschuh, Michael, Hirschmann, Wolf-Dietrich, Lechner, Klaus, Wassmann, Barbara, Falge, Christiane, Kirchner, Hartmut H., Gratwohl, Alois

Volltext

Chronic myeloid leukemia: a model for oncology von Hehlmann, Rüdiger, Berger, Ute, Hochhaus, Andreas

Volltext

Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia von Pfirrmann, Markus, Saussele, Susanne, Hochhaus, Andreas, Reiter, Andreas, Berger, Ute, Hossfeld, Dieter K., Nerl, Christoph, Scheid, Christof, Spiekermann, Karsten, Mayer, Jiri, Hellmann, Andrzej, Lechner, Klaus, Falge, Christiane, Sayer, Herbert G., Bunjes, Donald, Ganser, Arnold, Beelen, Dietrich W., Baldomero, Helen, Schanz, Urs, Heimpel, Hermann, Kolb, Hans-Jochem, Hasford, Joerg, Gratwohl, Alois, Hehlmann, Rüdiger

Volltext

Gender aspects in chronic myeloid leukemia: long-term results from randomized studies von BERGER, U, MAYWALD, O, LÖFFLER, H, PRALLE, H, QUEISSER, W, HEHLMANN, R, PFIRRMANN, M, LAHAYE, T, HOCHHAUS, A, REITER, A, HASFORD, J, HEIMPEL, H, HOSSFELD, D. K, KOLB, H.-J

Volltext

Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelo... von Pfirrmann, Markus, Saussele, Susanne, Hochhaus, Andreas, Reiter, Andreas, Berger, Ute, Hossfeld, Dieter K., Nerl, Christoph, Scheid, Christof, Spiekermann, Karsten, Mayer, Jiri, Falge, Christiane, Sayer, Herbert G., Bunjes, Donald, Ganser, Arnold, Beelen, Dietrich W., Baldomero, Helen, Schanz, Urs, Heimpel, Hermann, Hasford, Joerg, Kolb, Hans-Jochem, Gratwohl, Alois, Hehlmann, Rüdiger

Volltext

Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia : low levels of minimal residual disease are associated with... von HOCHHAUS, A, REITER, A, HEHLMANN, R, GOLDMAN, J. M, CROSS, N. C. P, SAUSSELE, S, REICHERT, A, EMIG, M, KAEDA, J, SCHULTHEIS, B, BERGER, U, SHEPHERD, P. C. A, ALLAN, N. C

Volltext

The European LeukemiaNet: achievements and perspectives von HEHLMANN, Rüdiger, GRIMWADE, David, BÜCHNER, Thomas, BURNETT, Alan, CROSS, Nicolas C. F, DE WITTE, Theo J. M, DÖHNER, Hartmut, DOMBRET, Hervé, EINSELE, Hermann, ENGELICH, Georg, FOA, Robin, FONATSCH, Christa, SIMONSSON, Bengt, GÖKBUGET, Nicola, GLUCKMAN, Elaine, GRATWOHL, Alois, GUILHOT, Francois, HAFERLACH, Claudia, HAFERLACH, Thorsten, HALLEK, Michael, HASFORD, Jörg, HOCHHAUS, Andreas, HOELZER, Dieter, APPERLEY, Jane, KILADJIAN, Jean-Jaques, LABAR, Boris, LJUNGMAN, Per, MANSMANN, Ulrich, NIEDERWIESER, Dietger, OSSENKOPPELE, Gert, RIBERA, Jose M, RIDER, Harald, SERVE, Hubert, SCHROTZ-KING, Petra, BACCARANI, Michele, SANZ, Miguel A, SAUSSELE, Susanne, BARBUI, Tiziano, BAROSI, Giovanni, BASSAN, Renato, BENE, Marie C, BERGER, Ute

Volltext

Balanced Scorecard für die Übungsfirma von Berger, Ute

Volltext bestellen

Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha... von Berger, U, Engelich, G, Reiter, A, Hochhaus, A, Hehlmann, R

Volltext

Autologous stem cell transplantation in chronic myeloid leukaemia: A meta-analysis of six randomized trials von CML Autograft Trials Collaboration

Volltext

Transient Response to Imatinib in an Atypical Chronic Myeloproliferative Disease Associated with ins(9;4)(q34;q21q31) and a CDK5RAP2-PDGFRA Fusion Gene von Walz, Christoph, Schultheis, Beate, Metzgeroth, Georgia, Schoch, Claudia, Curtis, Claire, Lengfelder, Eva, Haferlach, Torsten, Berger, Ute, Hochhaus, Andreas, Hehlmann, Rüdiger, Cross, Nicholas C.P., Reiter, Andreas

Volltext

Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC von Ernst, Thomas, Erben, Philipp, Schenk, Thomas, Mueller, Martin C., Emig, Michael, Kreil, Sebastian, La Rosée, Paul, Berger, Ute, Hehlmann, Ruediger, Hochhaus, Andreas

Volltext

Response and resistance in 300 patients with BCR‐ABL–positive leukemias treated with imatinib in a single center von Lahaye, Tanja, Riehm, Birte, Berger, Ute, Paschka, Peter, Müller, Martin C., Kreil, Sebastian, Merx, Kirsten, Schwindel, Uwe, Schoch, Claudia, Hehlmann, Rüdiger, Hochhaus, Andreas

Volltext

Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia von Brümmendorf, Tim H., Ersöz, Inci, Hartmann, Ulrike, Bartolovic, Kerol, Balabanov, Stefan, Wahl, Alexandra, Paschka, Peter, Kreil, Sebastian, Lahaye, Tanja, Berger, Ute, Gschaidmeier, Harald, Bokemeyer, Carsten, Hehlmann, Rüdiger, Dietz, Klaus, Lansdorp, Peter M., Kanz, Lothar, Hochhaus, Andreas

Volltext

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary von GUILHOT, Francois, HEHLMANN, Rüdiger, REITER, Andreas, HOSSFELD, Dieter K, HUBER, Christoph, LÖFFLER, Helmut, PRALLE, Hans, QUEISSER, Wolfgang, TOBLER, Andreas, NERL, Christoph, SOLENTHALER, Max, GOEBELER, Mariele E, BERGER, Ute, GRIESSHAMMER, Martin, FISCHER, Thomas, KREMERS, Stephan, EIMERMACHER, Hartmut, PFREUNDSCHUH, Michael, HIRSCHMANN, Wolf-Dietrich, LECHNER, Klaus, WASSMANN, Barbara, FALGE, Christiane, KIRCHNER, Hartmut H, PTIRRMANN, Markus, GRATWOHL, Alois, HEIMPEL, Hermann, HOCHHAUS, Andreas, HASFORD, Joerg, KOLB, Hans-Jochem, LAHAYE, Tanja, MAYWALD, Ole

Volltext

Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Pat... von BRÜMMENDORF, TIM H., ERSÖZ, INCI, HARTMANN, ULRIKE, BALABANOV, STEFAN, WOLKE, HOLGER, PASCHKA, PETER, LAHAYE, TANJA, BERNER, BIRGIT, BARTOLOVIC, KEROL, KREIL, SEBASTIAN, BERGER, UTE, GSCHAIDMEIER, HARALD, BOKEMEYER, CARSTEN, HEHLMANN, RÜDIGER, DIETZ, KLAUS, LANSDORP, PETER M., KANZ, LOTHAR, HOCHHAUS, ANDREAS

Volltext

Concept, Feasibility and Results of the Randomized Comparison of Imatinib Combination Therapies for Chronic Myeloid Leukemia: The German CML-Study IV von Berger, Ute, Hochhaus, Andreas, Pfirrmann, Markus, Schoch, Claudia, Reiter, Andreas, Ehninger, Gerhard, Fischer, Thomas, Gratwohl, Alois, Hasford, Joerg, Heimpel, Hermann, Hossfeld, Dieter K., Kolb, Hans-J., Krause, Stefan, Nerl, Christoph, Pralle, Hans, Tobler, Andreas, Hehlmann, Ruediger

Volltext

PEG-Interferon for Chronic Phase CML - Still an Option in the Era of Imatinib? von Scheid, Christof, Draube, Andreas, Holtick, Udo, Cornely, Oliver, Hacker, Ulrich, Fuchs, Michael, Berger, Ute, Hochhaus, Andreas, Hehlmann, Rüdiger, Hallek, Michael

Volltext